Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Articles
Articles
Number of Cancers Convincingly Linked to Obesity More Than Doubles
By
Charles Bankhead
Cancer Prevention
,
Personalized Medicine
October 2016, Vol 7, No 9
Read More
Patient Relationship Management: Novel Software for a New Era of Patient Navigation in Oncology
Patient Navigation
,
Policies & Guidelines
October 2016, Vol 7, No 9
As cancer care providers well know, the landscape of healthcare delivery is changing in complex and dramatic ways. Two related trends are driving this change: the shift among payers to value-based reimbursement, and rapidly evolving patient expectations.
Read More
Immunotherapy Moving into Prime Time
By
Nick Bryant
Immunotherapy
,
Personalized Medicine
October 2016, Vol 7, No 9
Read More
Molecular Subtypes Predict Response to Radiation in Prostate Cancer
By
Phoebe Starr
ASTRO Meeting Highlights
October 2016, Vol 7, No 9
Read More
Hypofractionated Radiation May Be New Treatment Paradigm in Patients Unable to Receive Standard of Care
By
Phoebe Starr
ASTRO Annual Meeting
October 2016, Vol 7, No 9
Read More
FDA News - October 2016
FDA Approvals, News & Updates
,
In the News
October 2016, Vol 7, No 9
Read More
Radiation Boost Improves Local Control, Spares Salvage Mastectomy in Patients with Ductal Carcinoma in Situ
By
Phoebe Starr
ASTRO Meeting Highlights
October 2016, Vol 7, No 9
Read More
Survival Increased with Value-Added Stereotactic Body Radiation Therapy in Patients with Lung Cancer
By
Phoebe Starr
ASTRO Meeting Highlights
October 2016, Vol 7, No 9
Read More
Hematopoietic-Cell Transplants Require Substantial All-Cause Healthcare Resource Utilization
By
Jessica Miller
Value in Oncology
October 2016, Vol 7, No 9
Read More
Palliative Care for Caregivers: Implementing Caregiver Support Programs
By
Chase Doyle
Palliative Care
,
Personalized Medicine
October 2016, Vol 7, No 9
Read More
Page 149 of 330
146
147
148
149
150
151
152
Top Trending Articles
1.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
2.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
3.
Financial Toxicity in Cancer Care: Why the Conversation Must Start Before Treatment Begins
Jan Hailey, MHL, CMC, CMCO, CMIS, CMOM, CMCA-E/M
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma